2nd EVOMET Annual Meeting strengthens the network and promotes the professional development of its membersThe 2nd Annual Meeting of EVOMET took place in Basel, Switzerland between the 4th to the 7th of October 2022. It was [...]
EVOMET Lausanne researchers develop novel strategy to noninvasively monitor key immune cells in tumorsA University of Lausanne study has developed a strategy to noninvasively track immune cells known as macrophages within brain and breast tumors [...]
Evomet starts its scientific production at the highest level: Nature paper from Dr Sakari Vanharanta and Leticia Castillon’s teamA study has identified how common genetic alterations lead to the development of kidney cancer by showing that the cancer forming capability [...]
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 955951